Fetal Neuroprotection with Magnesium Sulfate
Administration Guidelines
- The American College of Obstetricians and Gynecologists recommends administering a 4g IV loading dose of magnesium sulfate over 20-30 minutes, followed by a maintenance infusion of 1g/hour until delivery or for up to 24 hours maximum for fetal neuroprotection before anticipated preterm birth 1, 2
- For maintenance infusion, prepare by adding 20g magnesium sulfate to 500 mL NS, creating a 40 mg/mL solution, and set infusion rate at 25 mL/hour to deliver 1g/hour 1, 2
Critical Safety Measures
- Have calcium gluconate or calcium chloride immediately available at bedside to reverse potential magnesium toxicity 3, 4
- Monitor for magnesium toxicity, including loss of patellar reflexes, respiratory depression, hypotension, and bradycardia, with a target therapeutic serum magnesium level of 4.8-8.4 mg/dL 3
Evidence for Neuroprotection
- The American College of Obstetricians and Gynecologists recommends magnesium sulfate for fetal neuroprotection, based on five randomized controlled trials demonstrating a reduced risk of cerebral palsy (RR 0.68, 95% CI 0.54-0.87) without increasing mortality when administered before 30 weeks gestation 1
- The dosing regimen of 4g loading followed by 1g/hour maintenance has been validated in multiple trials and is the standard recommended by the American College of Obstetricians and Gynecologists 1, 2
- Monitoring magnesium levels is crucial, especially with frequent or prolonged dosing, as recommended by the American Heart Association, equivalent to the Circulation journal 5, 4